Page last updated: 2024-08-21

hesperidin and Acute Lung Injury

hesperidin has been researched along with Acute Lung Injury in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Geng, C; Li, F; Liu, X; Sun, H; Wang, N; Wang, X1
Chang, C; Dong, J; Zhao, H; Zhao, Y; Zhou, H1
Guan, M; Li, C; Li, Y; Lu, Y; Ye, J; Zhang, D; Zhou, C1
Hattori, T; Iizuka, S; Miura, A; Mogami, S; Nakazato, M; Tsubouchi, H; Yamada, C; Yanagi, S1
Chen, MJ; Gong, Q; Huang, WJ; Li, G; Liu, XX; Nie, H; Ren, BX; Sun, T; Wang, C; Yu, DD; Zhang, YX1

Other Studies

5 other study(ies) available for hesperidin and Acute Lung Injury

ArticleYear
Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4-MyD88-NF-κB signaling pathway.
    Archives of pharmacal research, 2019, Volume: 42, Issue:12

    Topics: Acute Lung Injury; Animals; Dose-Response Relationship, Drug; Hesperidin; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2019
Hesperetin ameliorates lipopolysaccharide-induced acute lung injury via the miR-410/SOX18 axis.
    Journal of biochemical and molecular toxicology, 2020, Volume: 34, Issue:12

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Enzyme-Linked Immunosorbent Assay; Hesperidin; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; MicroRNAs; SOXF Transcription Factors

2020
Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2.
    European journal of pharmacology, 2019, Jun-05, Volume: 852

    Topics: Acute Lung Injury; Animals; Cytoprotection; Gene Expression Regulation; Hesperidin; Humans; Lipopolysaccharides; Lung; Lymphocyte Antigen 96; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Targeted Therapy; Protein Conformation; RAW 264.7 Cells; Toll-Like Receptor 4

2019
Rikkunshito ameliorates bleomycin-induced acute lung injury in a ghrelin-independent manner.
    American journal of physiology. Lung cellular and molecular physiology, 2014, Volume: 306, Issue:3

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Apoptosis; Bleomycin; Disease Models, Animal; Drugs, Chinese Herbal; Eating; Epithelial Cells; Ghrelin; Glycyrrhizic Acid; Hesperidin; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; NF-kappa B; Pulmonary Alveoli; Pulmonary Fibrosis; Signal Transduction

2014
Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release.
    International immunopharmacology, 2015, Volume: 25, Issue:2

    Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cell Count; Cells, Cultured; Chemokine CCL2; Hesperidin; HMGB1 Protein; Interleukin-6; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice, Inbred BALB C; Peroxidase; Tumor Necrosis Factor-alpha

2015